National Cheng Kung University
Tainan, 70101, Taiwan
Location status: Recruiting
Location contact
Ching-Lan Lin, Doctor
CONTACT
+886-6-2757575 ext. 5038
Jou-Ting Lin, Master
CONTACT
+886-6-2757575 ext. 5038
NCT Number: NCT07340983
The goal of this randomized controlled trial is to evaluate the effectiveness of the Safe Haven app in reducing mental health symptoms and enhancing mental health literacy in undergraduates at a national university in southern Taiwan. The main questions it aims to answer are:
Does the Safe Haven app lead to significantly greater reductions in general psychological distress, depression, anxiety, and stress compared to standard campus care?
Does the app result in greater improvements in mental health literacy among participants?
Researchers will compare an experimental group (receiving the Safe Haven app in addition to standard campus care) to a waitlist control group (receiving standard campus care only) to see if the intervention provides superior improvements in mental health outcomes over time.
Participants will:
Complete online assessments at three time points: baseline (T0), post-intervention (3 months, T1), and follow-up (3 months post-intervention, T2).
Experimental Group: Download the Safe Haven app to complete daily mood self-monitoring and weekly assessments, and receive psychoeducational content, personalized suggestions for 3 months.
Control Group: Maintain access to standard campus care and receive access to the app after the final follow-up assessment.
Interested in participating?
Request Info18 year–24 year
All sexes
Interventional
Not applicable
Tainan, 70101, Taiwan
Location status: Recruiting
Ching-Lan Lin, Doctor
CONTACT
+886-6-2757575 ext. 5038
Jou-Ting Lin, Master
CONTACT
+886-6-2757575 ext. 5038
Background: Undergraduates face a critical transition period marked by significant stressors and a high prevalence of mental health issues. However, help-seeking behaviors remain low due to stigma and structural barriers. While mobile health (mHealth) apps offer a scalable solution, existing interventions often rely on static content and lack real-time responsiveness to students' fluctuating psychological states. This study introduces "Safe Haven," a Just-in-Time Adaptive Intervention (JITAI) system that integrates self-monitoring with risk stratification to provide tailored support. This study aims to evaluate the effectiveness of the Safe Haven app in reducing psychological distress and enhancing mental health literacy compared to standard campus care alone.
Study Design: This study employs a parallel-group, two-arm randomized controlled trial (RCT). A total of 68 eligible undergraduate students from a national university in southern Taiwan will be recruited. After completing baseline assessments (T0), participants will be randomized in a 1:1 ratio to either the Experimental Group or the Waitlist Control Group.
Intervention Details
Experimental Group (Safe Haven App + TAU): Participants in this group will receive access to the Safe Haven app for a duration of 3 months, in addition to maintaining full access to standard on-campus counseling and mental health services (Treatment-as-Usual, TAU). The Safe Haven app includes five core components:
Waitlist Control Group (TAU Only): Participants in this group will maintain access to standard on-campus counseling and mental health services (TAU) but will not access the Safe Haven app during the 3-month intervention period. To ensure ethical standards, these participants will be offered access to the Safe Haven app after completing the final follow-up assessment (T2).
Study Procedures Data collection will occur at three time points:
Outcome Measures The primary outcomes are changes in general psychological distress (measured by CHQ-12) and symptoms of depression, anxiety, and stress (measured by DASS-21). Secondary outcomes include changes in mental health literacy (measured by MHLS-HPG) and intervention engagement (measured by app usage logs and SUS scores).
Statistical Analysis Plan Data will be analyzed using IBM SPSS Statistics. The primary analysis will follow the Intention-to-Treat (ITT) principle. Generalized Estimating Equations (GEE) will be utilized to examine longitudinal changes and test the Group × Time interaction effect on outcome measures. GEE models will be adjusted for baseline scores of the respective outcome variables. Additionally, any demographic characteristics showing statistically significant differences between groups at baseline will be included as covariates. For the experimental group, further analyses will examine the association between objective engagement metrics (e.g., completion rates) and clinical improvements to determine dose-response relationships.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A Just-in-Time Adaptive Intervention (JITAI) mobile app that integrates self-monitoring, risk stratification, and tailored psychoeducation modules. The system provides real-time feedback and stepped-care support based on the user's psychological status.
Time frame: Baseline, Post-intervention (Month 3), and Follow-up (Month 6)
The Depression Anxiety Stress Scales-21 (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety, and stress. Each of the three subscales contains 7 items, scored on a 4-point Likert scale ranging from 0 ("Did not apply to me at all") to 3 ("Applied to me very much or most of the time"). Scores for Depression, Anxiety, and Stress are calculated by summing the scores for the relevant items. Subscale scores range from 0 to 21 (or 0 to 42 if multiplied by 2). Higher scores indicate greater severity of symptoms.
Time frame: Baseline, Post-intervention (Month 3), and Follow-up (Month 6)
The Chinese Health Questionnaire-12 (CHQ-12) is a self-report screening instrument used to assess general psychological distress and minor psychiatric morbidity. It consists of 12 items related to somatic and psychological symptoms. Higher scores indicate higher levels of psychological distress and poorer mental health status.
Time frame: Baseline, Post-intervention (Month 3), and Follow-up (Month 6)
The Mental Health Literacy Scale (MHLS-HPG) is a self-report measure assessing recognition, knowledge, and attitudes regarding mental health. It evaluates the ability to recognize disorders, knowledge of risk factors and professional help, and attitudes that promote help-seeking. Higher scores indicate higher levels of mental health literacy and more positive attitudes toward help-seeking.
Time frame: Continuously assessed over the 3-month intervention period and 3-month follow-up period
Objective engagement is measured via app usage logs to calculate two key ratios:
Daily Engagement Ratio: Defined as the number of days the participant logged into the app divided by the total number of days in the intervention period.
Weekly Engagement Ratio: Defined as the number of weeks in which the participant logged in at least once divided by the total intervention duration (12 weeks). Higher ratios indicate higher levels of behavioral engagement with the intervention.
Time frame: Post-intervention (Month 3), and Follow-up (Month 6)
Subjective engagement and satisfaction are assessed using the System Usability Scale (SUS). The SUS consists of 10 items scored on a 5-point Likert scale ranging from 1 ("Strongly Disagree") to 5 ("Strongly Agree"). The final score is converted to a range of 0 to 100. A score above 68 is considered to indicate above-average usability. Higher scores represent better user experience and subjective engagement.
Contact information is provided by the study sponsor or research team.
National Cheng-Kung University Hospital
Other
The Effectiveness of the Safe Haven APP on Mental Health Among Undergraduates: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05322343
Aging, Alzheimer Disease
Bordeaux, France
View Trial DetailsNCT06644573
Alzheimer Disease, Alzheimer Disease or Associated Disorder
Aventura, Florida, United States
View Trial DetailsNCT05027113
Alzheimer Disease, Anxiety
Los Angeles, California, United States
View Trial DetailsNCT05292560
Adults, Alzheimer Disease
Enschede, Overijssel, Netherlands
View Trial Details